The authors reply

Affiliations

¹ Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA; Veterans Affairs Medical Center, West Haven, Connecticut, USA. Electronic address: mark.perazella@yale.edu.
² Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, Virginia, USA.
³ Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia, USA.

Free article

Comment

Mark A Perazella et al. Kidney Int. 2018 Dec.

Free article

. 2018 Dec;94(6):1238-1239.

doi: 10.1016/j.kint.2018.08.023.

¹ Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA; Veterans Affairs Medical Center, West Haven, Connecticut, USA. Electronic address: mark.perazella@yale.edu.
² Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, Virginia, USA.
³ Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia, USA.

No abstract available

Comment on

Renal cell carcinoma for the nephrologist.
Perazella MA, Dreicer R, Rosner MH. Perazella MA, et al. Kidney Int. 2018 Sep;94(3):471-483. doi: 10.1016/j.kint.2018.01.023. Epub 2018 Apr 14. Kidney Int. 2018. PMID: 29661544 Review.
Screening for renal cell carcinoma in dialysis patients.
Liakopoulos V, Eleftheriadis T, Mertens PR. Liakopoulos V, et al. Kidney Int. 2018 Dec;94(6):1238. doi: 10.1016/j.kint.2018.08.032. Kidney Int. 2018. PMID: 30466567 No abstract available.